Overcoming Obesity 2023 (Live) -Pediatric Obesity: Rolling with Resistance
Recent AAP obesity guidelines point out that "watchful waiting" can delay treatment. Instead, they recommend to intervene sooner with intensive health behavior and lifestyle treatment, pharmacotherapy and metabolic and bariatric surgery. This has stirred up concern from patients, families, media, and even medical professionals that this may be too aggressive. During this session, key statements from the AAP obesity clinical practice guidelines and the OMA pediatric obesity algorithm will be identified, evidence behind these recommendations will be reviewed, and common hesitancies, stigma and bias will be explored. The session will conclude with a case-based series to explore patient-family-provider scenarios and effective anecdotes.
CME/CE Expiration Date: 11/28/23
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
- Outline the perceived vs evidenced-based expectations of pediatric patients with obesity.
- Examine for both internal and external bias and stigma relating to pediatric patients with obesity.
- Describe the effective assessment and treatment strategies for the treatment of obesity in pediatric patients.
- Describe common scenarios of reluctance and resistant when treating obesity in pediatric patients.
- Discuss strategies to address reluctance and resistance when treating obesity in pediatric patients.
Jennifer Hosterman, DO, FAAP
- 1.00 AMA PRA Category 1 Credit™The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Obesity Medicine Association designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.